Abstract
The radical-ionic coupling of chloropyrazine-2-carboxylic acid derivatives with methoxybenzenethiols, carried out in the presence of a heterogeneous copper catalyst, provided the series of 6- or 5- or 3-(4-methoxyphenyl)sulfanylpyrazine- 2-carboxylic acid derivatives as well as 6- or 5- or 3-(3-methoxyphenyl)sulfanylpyrazine-2-carboxylic acid derivatives. The prepared compounds were evaluated as potential antifungal agents and new antituberculotics. Their preliminary in vitro evaluation of antimycobacterial activity according to the international program with the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) is presented. Several compounds showed an interesting activity in the preliminary screening with a percentage growth inhibition of the virulent Mycobacterium tuberculosis H37Rv between 50 to 100% at the concentration 6.25 μg/mL. Structure-activity relationships among the chemical structure, the physical properties and the biological activities of the evaluated compounds are discussed in the article.
Keywords: Methoxyphenylsulfanylpyrazine-2-carboxylic acid derivatives, in vitro antimycobacterial activity, in vitro antifungal activity, lipophilicity, structure-activity relationships
Medicinal Chemistry
Title: Antimicrobial Evaluation of Some Arylsulfanylpyrazinecarboxylic Acid Derivatives
Volume: 3 Issue: 3
Author(s): Josef Jampilek, Martin Dolezal and Vladimir Buchta
Affiliation:
Keywords: Methoxyphenylsulfanylpyrazine-2-carboxylic acid derivatives, in vitro antimycobacterial activity, in vitro antifungal activity, lipophilicity, structure-activity relationships
Abstract: The radical-ionic coupling of chloropyrazine-2-carboxylic acid derivatives with methoxybenzenethiols, carried out in the presence of a heterogeneous copper catalyst, provided the series of 6- or 5- or 3-(4-methoxyphenyl)sulfanylpyrazine- 2-carboxylic acid derivatives as well as 6- or 5- or 3-(3-methoxyphenyl)sulfanylpyrazine-2-carboxylic acid derivatives. The prepared compounds were evaluated as potential antifungal agents and new antituberculotics. Their preliminary in vitro evaluation of antimycobacterial activity according to the international program with the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) is presented. Several compounds showed an interesting activity in the preliminary screening with a percentage growth inhibition of the virulent Mycobacterium tuberculosis H37Rv between 50 to 100% at the concentration 6.25 μg/mL. Structure-activity relationships among the chemical structure, the physical properties and the biological activities of the evaluated compounds are discussed in the article.
Export Options
About this article
Cite this article as:
Jampilek Josef, Dolezal Martin and Buchta Vladimir, Antimicrobial Evaluation of Some Arylsulfanylpyrazinecarboxylic Acid Derivatives, Medicinal Chemistry 2007; 3 (3) . https://dx.doi.org/10.2174/157340607780620635
DOI https://dx.doi.org/10.2174/157340607780620635 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB
Current Topics in Medicinal Chemistry The Expanding Role of Tumor Necrosis Factor-α Inhibitors in the Management of Rheumatic Diseases
Medicinal Chemistry Reviews - Online (Discontinued) Recent Patents on Oral Combination Drug Delivery and Formulations
Recent Patents on Drug Delivery & Formulation Astrocytes and Inflammasome: A Possible Crosstalk in Neurological Diseases
Current Medicinal Chemistry Preparation of Knockout Extract for Determination of Really Active Compound Using MAb
Current Drug Discovery Technologies Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry The Impending Renaissance in Discovery & Development of Natural Products
Current Topics in Medicinal Chemistry Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study
Current HIV Research Synthesis and SAR of Some New 4 Substituted 3H-1,2,3,5-oxathiadiazole 2-Oxides as Antifungal Agents
Letters in Drug Design & Discovery Gold Nanoparticle-Mediated High-Performance Enzyme-Linked Immunosorbent Assay for Detection of Tuberculosis ESAT-6 Protein
Micro and Nanosystems Gene Expression Profiling Analysis to Identify Key Genes and Underlying Mechanisms in Meniscus of Osteoarthritis Patients
Combinatorial Chemistry & High Throughput Screening Novel, Unifying Phagomimetic Mechanism of Vancomycin Therapeutic Action and Toxicity: Polyphenol, Electron Transfer and Reactive Oxygen Species
Anti-Infective Agents in Medicinal Chemistry Efficient and Green One-Pot Multi-Component Synthesis of α-Aminophosphonates Catalyzed by Zinc Triflate
Current Organic Synthesis Molecular Tools for Typing and Branding the Tubercle Bacillus
Current Molecular Medicine Natural Bioactives as Potential Therapeutic Modalities Against NeuroAIDS
Current Topics in Medicinal Chemistry Current Understanding of Dietary Polyphenols and their Role in Health and Disease
Current Nutrition & Food Science Update of QSAR & Docking & Alignment Studies of the DNA Polymerase Inhibitors
Current Bioinformatics Mucosal Delivery of Vaccines: Role of Mucoadhesive/Biodegradable Polymers
Recent Patents on Drug Delivery & Formulation Biologically Active 4-Thiazolidinones: A Review of QSAR Studies and QSAR Modeling of Antitumor Activity
Current Topics in Medicinal Chemistry The Role of Hyphenated Chromatography-Mass Spectrometry Techniques in Exploratory Drug Metabolism and Pharmacokinetics
Current Pharmaceutical Design